Document is current

Article History

Received: 30 August 2025

Accepted: 27 March 2026

First Online: 22 April 2026

Declarations

:

: D.C., in the last 2 years, has participated in educational meetings and/or attended a conferences or symposia (including travel, accommodation and/or hospitality), and/or received honoraria for consulting or lecturing from Daiichi Sankyo, Menarini, outside the scope of this work. F.J.P received honoraria for consulting or lecturing from Boehringer-Ingelheim, Bayer Healthcare, Novartis, Menarini, Servier, Daichi Sankyo, Vifor International, Pfizer outside the scope of this work. The other authors do not have any conflicts of interest to disclose.

: Conceptualization: D.C. ; methodology: D.C.; software management: R.A.B, A.L, L.P., D.C. ; validation: D.C., M.A., R.A.B, A.L, L.P. and F.J.P.; formal analysis: D.C.; Data retrieval and curation: R.A.B, A.L, L.P., D.C.; writing—original draft preparation: D.C.; critical appraisal, writing—review and editing with substantial contributions: D.C., M.A., R.A.B, A.L, L.P. and F.J.P.; all authors have read and agreed to the published version of the manuscript.

: The data were pooled based on published meta-data.

: Not applicable.

: Not applicable.

: Not applicable.